The clinical trials below are available in the specialty you selected. Choose a different specialty.

Neurobehavioral Research of HIV and Cocaine
The purpose is to examine neurobehavioral functioning in persons with HIV and/or cocaine dependence. The age range of our population is from 20 to 60 years old. The study includes up to 3 visits depending upon eligibility and participants can earn up to $180 for completion of all three study visits. The visits include a screening, a neuropsychological assessment visit, and an fMRI brain scan. No drugs or treatment are provided in this study. (REF# 00016338)

Strategic Timing of Antiretroviral Therapy (START)
HIV patients are needed for a study examining the most effective time to begin antiretroviral treatment. (REF# 27264)

Treatment Experienced Bristol-Meyers Squibb (BMS) Study
This is a phase IIb randomized, controlled, partially-blinded trial to investigate safety, efficacy, and dose-response of BMS-663068 in tx experienced HIV-1 subjects, followed by an open-label period on the recommended dose. (REF# 31249)

Impulsivity and Behavioral Risk in HIV Patients with Mood Disorders
We are conducting a study on impulsivity, HIV/AIDS, and mood disorders like depression or bipolar (manic-depression).
(REF# 18974)

Neurobehavioral and fMRI Research in HIV Infection and Cocaine Dependence
We are conducting a study on HIV/AIDS and cocaine use. If you qualify for participation, you could earn up to $180 for three study visits. (REF# 16338)

Effect of HDL-Raising Therapies on HIV Subjects with Low HDL Cholesterol (A5293)
HIV-infected people with low levels of high-density lipoprotein cholesterol (HDL-C) and elevated triglycerides are needed for a study comparing HDL-C raising medications. (REF# 31384)